Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications consumer willingness pay “second generation” genetically engineered products role
… treatment development, current strategies for evidence generation and communication of unmet need and product value …
… from respondents who were asked to rate their willingness to recommend their own employer to friends and …
… for Dermatologic Surgery Annual Meeting. Patients' willingness to accept adverse event and cost trade-offs for …
… compared to other types of dementia. Antipsychotics are a second-line treatment for this condition, but an increased …
… technology (medtech) developers prepare for making their products available to patients and providers, navigating the … They often find themselves asking questions such as, what products and services require HTA approval? Are apps, digital … Key evidence considerations for medtech HTA, including the role of real-world evidence How medtech HTA processes and …
… and analytic challenges related to the safety of medical products, with a focus on rheumatology and ophthalmology. …
… clinical studies involving drugs, devices, and biological products. Compliance with these guidelines will be mandatory … undoubtedly increases the burden on developers of medical products who are continually striving to shorten development … to guarantee the safe and effective use of new medical products, the outlined approach presents challenges. It will …
… France, enhances our capabilities in real-world evidence generation Real-world evidence plays a critical role in product strategy and healthcare decision-making. With …
… and support optimal measurement strategies for your products in development, including: Literature and instrument …
… set into as many exposure groups as you want to study, second, censoring those clones when they deviate from their …